USPTO serial 99493224
BIO-TECHNE
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- RUMMERY, MARY M
- Law office
- TMO LAW OFFICE 117
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIO-TECHNE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MINNEAPOLIS, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Courtney Thompson
Courtney Thompson Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents and chemicals for scientific purposes, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and diagnostic reagents for scientific use; reagents, namely recombinant proteins and antibodies, for scientific research, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and diagnostic reagents for scientific use; biological cell culture media for scientific purposes, medical research, clinical research, life science research, laboratory research, and pharmaceutical research; biological cell culture media for diagnostic use for scientific purposes; assays for research purposes; fluorescent dye for scientific purposes and in the fields of medical research, clinical research, life science research, laboratory research, pharmaceutical research, and for diagnostic use for scientific purposes; oligonucleotides for scientific use, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and for diagnostic use for scientific purposes; enzymes for scientific and research purposes | ACTIVE | — |
| 005 | Reagents and diagnostic reagents for clinical medical use; chemicals for clinical medical use, namely, for diagnosing, detecting, prognosing, stratifying or selecting therapy for a disease condition, including cancer and inherited genetic disorders; antibodies for medical purposes; protein arrays for medical diagnosis purposes; oligonucleotides for medical diagnostic purposes; culture media for cultivating human and animal cells for medical or clinical use; reagents and media for medical and veterinary diagnostic purposes; biological reagents, namely, clinical medical reagents; diagnostic preparations for medical laboratory purposes through use of the western blotting technique | ACTIVE | — |
| 009 | Instrumentation for life science research, namely, instruments to identify, quantify, and characterize proteins, analyze particles in biological samples, perform immunoassays, and to dispense and characterize cells in the nature of namely, protein detection and analysis instruments being automated western blot and imaged capillary electrophoresis instruments, immunoassay instruments, cell sorter and single cell dispenser instruments, and cell and tissue imaging analysis systems; instrumentation for life science research, namely, instruments for quality control and analysis in the manufacture of therapeutic products in the nature of micro-flow imaging systems; multiplexers; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in microtiter plates; microplate readers in the nature of apparatuses and instruments used to detect and measure absorbance at different light wavelengths for immunoassays; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in plates for research, bioassays, drug discovery, and manufacturing; protein analysis equipment comprised of computer hardware, recorded software, and display screens for protein detection, imaging, and quantitative analysis for use in genetic research, antibody research, biomarker discovery, and biotherapeutics production; laboratory apparatus, namely, protein sample fractionators; computer hardware and peripherals; downloadable software for multiplexing; laboratory apparatus, namely, electrophoresis apparatus not for medical purposes, in particular for western blot processing | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes used in medical laboratories, namely, electophoresis apparatus for western blot processing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 12, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 12, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 8, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2025 | NWAP | NEW APPLICATION ENTERED | — |